- call +1-201-465-4211
- email sales@mrinsights.biz
According to this latest study, the 2021 growth of Dalfampridine will have significant change from previous year. By the most conservative estimates of global Dalfampridine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Dalfampridine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Dalfampridine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
10 mg
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospitals
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Acorda Therapeutics
Elan Pharma
Biogen
Sun Pharmaceutical
Aurobindo Pharma
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dalfampridine Consumption 2016-2026
2.1.2 Dalfampridine Consumption CAGR by Region
2.2 Dalfampridine Segment by Type
2.2.1 10 mg
2.2.2 Others
2.3 Dalfampridine Sales by Type
2.3.1 Global Dalfampridine Sales Market Share by Type (2016-2021)
2.3.2 Global Dalfampridine Revenue and Market Share by Type (2016-2021)
2.3.3 Global Dalfampridine Sale Price by Type (2016-2021)
2.4 Dalfampridine Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Dalfampridine Sales by Application
2.5.1 Global Dalfampridine Sale Market Share by Application (2016-2021)
2.5.2 Global Dalfampridine Revenue and Market Share by Application (2016-2021)
2.5.3 Global Dalfampridine Sale Price by Application (2016-2021)
3 Global Dalfampridine by Company
3.1 Global Dalfampridine Sales Market Share by Company
3.1.1 Global Dalfampridine Sales by Company (2019-2021)
3.1.2 Global Dalfampridine Sales Market Share by Company (2019-2021)
3.2 Global Dalfampridine Revenue Market Share by Company
3.2.1 Global Dalfampridine Revenue by Company (2019-2021)
3.2.2 Global Dalfampridine Revenue Market Share by Company (2019-2021)
3.3 Global Dalfampridine Sale Price by Company
3.4 Global Manufacturers Dalfampridine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dalfampridine Product Location Distribution
3.4.2 Players Dalfampridine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Dalfampridine by Region
4.1 Global Dalfampridine by Region
4.1.1 Global Dalfampridine Sales by Region
4.1.2 Global Dalfampridine Revenue by Region
4.2 Americas Dalfampridine Sales Growth
4.3 APAC Dalfampridine Sales Growth
4.4 Europe Dalfampridine Sales Growth
4.5 Middle East & Africa Dalfampridine Sales Growth
5 Americas
5.1 Americas Dalfampridine Sales by Country
5.1.1 Americas Dalfampridine Sales by Country (2016-2021)
5.1.2 Americas Dalfampridine Revenue by Country (2016-2021)
5.2 Americas Dalfampridine Sales by Type
5.3 Americas Dalfampridine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dalfampridine Sales by Region
6.1.1 APAC Dalfampridine Sales by Region (2016-2021)
6.1.2 APAC Dalfampridine Revenue by Region (2016-2021)
6.2 APAC Dalfampridine Sales by Type
6.3 APAC Dalfampridine Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Dalfampridine by Country
7.1.1 Europe Dalfampridine Sales by Country (2016-2021)
7.1.2 Europe Dalfampridine Revenue by Country (2016-2021)
7.2 Europe Dalfampridine Sales by Type
7.3 Europe Dalfampridine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Dalfampridine by Country
8.1.1 Middle East & Africa Dalfampridine Sales by Country (2016-2021)
8.1.2 Middle East & Africa Dalfampridine Revenue by Country (2016-2021)
8.2 Middle East & Africa Dalfampridine Sales by Type
8.3 Middle East & Africa Dalfampridine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Dalfampridine Distributors
10.3 Dalfampridine Customer
11 Global Dalfampridine Market Forecast
11.1 Global Dalfampridine Forecast by Region
11.1.1 Global Dalfampridine Forecast by Regions (2021-2026)
11.2.2 Global Dalfampridine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Dalfampridine Forecast by Type
11.7 Global Dalfampridine Forecast by Application
12 Key Players Analysis
12.1 Acorda Therapeutics
12.1.1 Acorda Therapeutics Company Information
12.1.2 Acorda Therapeutics Dalfampridine Product Offered
12.1.3 Acorda Therapeutics Dalfampridine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Acorda Therapeutics Main Business Overview
12.1.5 Acorda Therapeutics Latest Developments
12.2 Elan Pharma
12.2.1 Elan Pharma Company Information
12.2.2 Elan Pharma Dalfampridine Product Offered
12.2.3 Elan Pharma Dalfampridine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Elan Pharma Main Business Overview
12.2.5 Elan Pharma Latest Developments
12.3 Biogen
12.3.1 Biogen Company Information
12.3.2 Biogen Dalfampridine Product Offered
12.3.3 Biogen Dalfampridine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Biogen Main Business Overview
12.3.5 Biogen Latest Developments
12.4 Sun Pharmaceutical
12.4.1 Sun Pharmaceutical Company Information
12.4.2 Sun Pharmaceutical Dalfampridine Product Offered
12.4.3 Sun Pharmaceutical Dalfampridine Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Sun Pharmaceutical Main Business Overview
12.4.5 Sun Pharmaceutical Latest Developments
12.5 Aurobindo Pharma
12.5.1 Aurobindo Pharma Company Information
12.5.2 Aurobindo Pharma Dalfampridine Product Offered
12.5.3 Aurobindo Pharma Dalfampridine Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Aurobindo Pharma Main Business Overview
12.5.5 Aurobindo Pharma Latest Developments
...
13 Research Findings and Conclusion
List of Tables
Table 1. Dalfampridine Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of 10 mg
Table 3. Major Players of Others
Table 4. Global Dalfampridine Sales by Type (2016-2021) & (K Units)
Table 5. Global Dalfampridine Sales Market Share by Type (2016-2021)
Table 6. Global Dalfampridine Revenue by Type (2016-2021) & ($ million)
Table 7. Global Dalfampridine Revenue Market Share by Type (2016-2021)
Table 8. Global Dalfampridine Sale Price by Type (2016-2021)
Table 9. Global Dalfampridine Sales by Application (2016-2021) & (K Units)
Table 10. Global Dalfampridine Sales Market Share by Application (2016-2021)
Table 11. Global Dalfampridine Value by Application (2016-2021)
Table 12. Global Dalfampridine Revenue Market Share by Application (2016-2021)
Table 13. Global Dalfampridine Sale Price by Application (2016-2021)
Table 14. Global Dalfampridine Sales by Company (2019-2021) & (K Units)
Table 15. Global Dalfampridine Sales Market Share by Company (2019-2021)
Table 16. Global Dalfampridine Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Dalfampridine Revenue Market Share by Company (2019-2021)
Table 18. Global Dalfampridine Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Dalfampridine Producing Area Distribution and Sales Area
Table 20. Players Dalfampridine Products Offered
Table 21. Dalfampridine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Dalfampridine Sales by Region (2016-2021) (K Units)
Table 25. Global Dalfampridine Sales Market Share by Region (2016-2021)
Table 26. Global Dalfampridine Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Dalfampridine Revenue Market Share by Region (2016-2021)
Table 28. Americas Dalfampridine Sales by Country (2016-2021) & (K Units)
Table 29. Americas Dalfampridine Sales Market Share by Country (2016-2021)
Table 30. Americas Dalfampridine Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Dalfampridine Revenue Market Share by Country (2016-2021)
Table 32. Americas Dalfampridine Sales by Type (2016-2021) & (K Units)
Table 33. Americas Dalfampridine Sales Market Share by Type (2016-2021)
Table 34. Americas Dalfampridine Sales by Application (2016-2021) & (K Units)
Table 35. Americas Dalfampridine Sales Market Share by Application (2016-2021)
Table 36. APAC Dalfampridine Sales by Region (2016-2021) & (K Units)
Table 37. APAC Dalfampridine Sales Market Share by Region (2016-2021)
Table 38. APAC Dalfampridine Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Dalfampridine Revenue Market Share by Region (2016-2021)
Table 40. APAC Dalfampridine Sales by Type (2016-2021) & (K Units)
Table 41. APAC Dalfampridine Sales Market Share by Type (2016-2021)
Table 42. APAC Dalfampridine Sales by Application (2016-2021) & (K Units)
Table 43. APAC Dalfampridine Sales Market Share by Application (2016-2021)
Table 44. Europe Dalfampridine Sales by Country (2016-2021) & (K Units)
Table 45. Europe Dalfampridine Sales Market Share by Country (2016-2021)
Table 46. Europe Dalfampridine Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Dalfampridine Revenue Market Share by Country (2016-2021)
Table 48. Europe Dalfampridine Sales by Type (2016-2021) & (K Units)
Table 49. Europe Dalfampridine Sales Market Share by Type (2016-2021)
Table 50. Europe Dalfampridine Sales by Application (2016-2021) & (K Units)
Table 51. Europe Dalfampridine Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Dalfampridine Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Dalfampridine Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Dalfampridine Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Dalfampridine Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Dalfampridine Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Dalfampridine Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Dalfampridine Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa Dalfampridine Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Dalfampridine
Table 61. Key Application and Potential Industries of Dalfampridine
Table 62. Key Challenges of Dalfampridine
Table 63. Key Trends of Dalfampridine
Table 64. Dalfampridine Distributors List
Table 65. Dalfampridine Customer List
Table 66. Global Dalfampridine Sales Forecast by Region (2021-2026) & (K Units)
Table 67. Global Dalfampridine Consumption Market Forecast by Region
Table 68. Global Dalfampridine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Dalfampridine Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Dalfampridine Sales Forecast by Country (2021-2026) & (K Units)
Table 71. Americas Dalfampridine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Dalfampridine Sales Forecast by Region (2021-2026) & (K Units)
Table 73. APAC Dalfampridine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Dalfampridine Sales Forecast by Country (2021-2026) & (K Units)
Table 75. Europe Dalfampridine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Dalfampridine Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Middle East & Africa Dalfampridine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Dalfampridine Sales Forecast by Type (2021-2026) & (K Units)
Table 79. Global Dalfampridine Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Dalfampridine Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Dalfampridine Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Dalfampridine Sales Forecast by Application (2021-2026) & (K Units)
Table 83. Global Dalfampridine Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Dalfampridine Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Dalfampridine Revenue Market Share Forecast by Application (2021-2026)
Table 86. Acorda Therapeutics Basic Information, Dalfampridine Manufacturing Base, Sales Area and Its Competitors
Table 87. Acorda Therapeutics Dalfampridine Product Offered
Table 88. Acorda Therapeutics Dalfampridine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 89. Acorda Therapeutics Main Business
Table 90. Acorda Therapeutics Latest Developments
Table 91. Elan Pharma Basic Information, Dalfampridine Manufacturing Base, Sales Area and Its Competitors
Table 92. Elan Pharma Dalfampridine Product Offered
Table 93. Elan Pharma Dalfampridine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 94. Elan Pharma Main Business
Table 95. Elan Pharma Latest Developments
Table 96. Biogen Basic Information, Dalfampridine Manufacturing Base, Sales Area and Its Competitors
Table 97. Biogen Dalfampridine Product Offered
Table 98. Biogen Dalfampridine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 99. Biogen Main Business
Table 100. Biogen Latest Developments
Table 101. Sun Pharmaceutical Basic Information, Dalfampridine Manufacturing Base, Sales Area and Its Competitors
Table 102. Sun Pharmaceutical Dalfampridine Product Offered
Table 103. Sun Pharmaceutical Dalfampridine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 104. Sun Pharmaceutical Main Business
Table 105. Sun Pharmaceutical Latest Developments
Table 106. Aurobindo Pharma Basic Information, Dalfampridine Manufacturing Base, Sales Area and Its Competitors
Table 107. Aurobindo Pharma Dalfampridine Product Offered
Table 108. Aurobindo Pharma Dalfampridine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 109. Aurobindo Pharma Main Business
Table 110. Aurobindo Pharma Latest Developments
List of Figures
Figure 1. Picture of Dalfampridine
Figure 2. Dalfampridine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dalfampridine Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Dalfampridine Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Dalfampridine Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of 10 mg
Figure 10. Product Picture of Others
Figure 11. Global Dalfampridine Sales Market Share by Type in 2020
Figure 12. Global Dalfampridine Revenue Market Share by Type (2016-2021)
Figure 13. Dalfampridine Consumed in Hospitals
Figure 14. Global Dalfampridine Market: Hospitals (2016-2021) & (K Units)
Figure 15. Dalfampridine Consumed in Clinics
Figure 16. Global Dalfampridine Market: Clinics (2016-2021) & (K Units)
Figure 17. Dalfampridine Consumed in Others
Figure 18. Global Dalfampridine Market: Others (2016-2021) & (K Units)
Figure 19. Global Dalfampridine Sales Market Share by Application (2016-2021)
Figure 20. Global Dalfampridine Revenue Market Share by Application in 2020
Figure 21. Dalfampridine Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Dalfampridine Revenue Market Share by Company in 2020
Figure 23. Global Dalfampridine Sales Market Share by Regions (2016-2021)
Figure 24. Global Dalfampridine Revenue Market Share by Region in 2020
Figure 25. Americas Dalfampridine Sales 2016-2021 (K Units)
Figure 26. Americas Dalfampridine Revenue 2016-2021 ($ Millions)
Figure 27. APAC Dalfampridine Sales 2016-2021 (K Units)
Figure 28. APAC Dalfampridine Revenue 2016-2021 ($ Millions)
Figure 29. Europe Dalfampridine Sales 2016-2021 (K Units)
Figure 30. Europe Dalfampridine Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Dalfampridine Sales 2016-2021 (K Units)
Figure 32. Middle East & Africa Dalfampridine Revenue 2016-2021 ($ Millions)
Figure 33. Americas Dalfampridine Sales Market Share by Country in 2020
Figure 34. Americas Dalfampridine Revenue Market Share by Country in 2020
Figure 35. Americas Dalfampridine Sales Market Share by Type in 2020
Figure 36. Americas Dalfampridine Sales Market Share by Application in 2020
Figure 37. United States Dalfampridine Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Dalfampridine Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Dalfampridine Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Dalfampridine Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Dalfampridine Sales Market Share by Region in 2020
Figure 42. APAC Dalfampridine Revenue Market Share by Regions in 2020
Figure 43. APAC Dalfampridine Sales Market Share by Type in 2020
Figure 44. APAC Dalfampridine Sales Market Share by Application in 2020
Figure 45. China Dalfampridine Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Dalfampridine Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Dalfampridine Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Dalfampridine Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Dalfampridine Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Dalfampridine Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Dalfampridine Sales Market Share by Country in 2020
Figure 52. Europe Dalfampridine Revenue Market Share by Country in 2020
Figure 53. Europe Dalfampridine Sales Market Share by Type in 2020
Figure 54. Europe Dalfampridine Sales Market Share by Application in 2020
Figure 55. Germany Dalfampridine Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Dalfampridine Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Dalfampridine Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Dalfampridine Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Dalfampridine Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Dalfampridine Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Dalfampridine Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Dalfampridine Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Dalfampridine Sales Market Share by Application in 2020
Figure 64. Egypt Dalfampridine Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Dalfampridine Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Dalfampridine Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Dalfampridine Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Dalfampridine Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
